457 related articles for article (PubMed ID: 8960389)
1. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
Tyagi SC; Kumar S; Cassatt S; Parker JL
Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
[TBL] [Abstract][Full Text] [Related]
3. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
4. Responses of vascular smooth muscle cell to extracellular matrix degradation.
Tummalapalli CM; Tyagi SC
J Cell Biochem; 1999 Dec; 75(3):515-27. PubMed ID: 10536373
[TBL] [Abstract][Full Text] [Related]
5. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells.
Tyagi SC; Kumar S; Katwa L
J Mol Cell Cardiol; 1997 Jan; 29(1):391-404. PubMed ID: 9040053
[TBL] [Abstract][Full Text] [Related]
7. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
8. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
10. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin.
Weihrauch D; Lohr NL; Mraovic B; Ludwig LM; Chilian WM; Pagel PS; Warltier DC; Kersten JR
Circulation; 2004 May; 109(19):2343-8. PubMed ID: 15136506
[TBL] [Abstract][Full Text] [Related]
11. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
[TBL] [Abstract][Full Text] [Related]
12. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
13. Vasculogenesis and angiogenesis: extracellular matrix remodeling in coronary collateral arteries and the ischemic heart.
Tyagi SC
J Cell Biochem; 1997 Jun; 65(3):388-94. PubMed ID: 9138094
[TBL] [Abstract][Full Text] [Related]
14. Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions.
Tyagi SC; Meyer L; Kumar S; Schmaltz RA; Reddy HK; Voelker DJ
Can J Cardiol; 1996 Apr; 12(4):353-62. PubMed ID: 8608454
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
19. Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Beger HG; Adler G
Z Gastroenterol; 1994 Apr; 32(4):221-5. PubMed ID: 8017097
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
